New malaria vaccines show promise in protecting indonesian soldiers

NCT ID NCT03503058

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two experimental malaria vaccines in 345 healthy Indonesian soldiers deployed to a malaria-endemic region. One vaccine uses weakened malaria parasites, and the other uses live parasites with a preventive drug. The goal was to see if either vaccine could safely prevent natural malaria infection. Results will help determine if these vaccines can protect people in high-risk areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two malaria vaccines: PfSPZ Vaccine (weakened malaria parasites) and PfSPZ-CVac (live malaria parasites given with chloroquine to prevent infection)
What this could lead to
If successful, this could lead to an effective vaccine that protects people living in or traveling to malaria-endemic areas from getting sick.
What could go wrong
This is a phase 2 trial with 345 participants, so results may not apply to larger populations. The vaccines may not provide strong or lasting protection, and side effects like fever or injection site reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Internal Medicine, Universitas Indonesia

    Jakarta, 10430, Indonesia

  • Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology

    Jakarta, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.